Showing results (1681-1690 of 1,770) with videos related to
Sort By:
Pageof 177
Gastroenterology|August 12, 2019
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir TherapyAnna S Lok, Mark S Sulkowski, Jens J Kort, et al.Science Translational Medicine|March 2, 2021
TCR β chain-directed bispecific antibodies for the treatment of T cell cancersSuman Paul, Alexander H Pearlman, Jacqueline Douglass, et al.Gastroenterology|June 16, 2016
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair GenesStacey A Cohen, Emily H Turner, Mallory B Beightol, et al.BMC Genomics|November 28, 2008
Refined annotation and assembly of the Tetrahymena thermophila genome sequence through EST analysis, comparative genomic hybridization, and targeted gap closureRobert S Coyne, Mathangi Thiagarajan, Kristie M Jones, et al.Annals of Hepatology|October 15, 2016
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infectionMaribel Rodriguez-Torres, Eric Lawitz, Bienvenido Yangco, et al.Gastroenterology|August 4, 2016
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 TrialEric Lawitz, Nancy Reau, Federico Hinestrosa, et al.BMJ Open Gastroenterology|July 6, 2019
Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndromeMegan P Hitchins, Ingrid P Vogelaar, Kevin Brennan, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 2025
13th Annual Symposium on Global Cancer Research: Reflections on Growth, Adaptation, and Commitment to Global Cancer ControlLinsey Eldridge, María T Bourlon, Eduardo Cazap, et al.Lancet (London, England)|August 1, 2014
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised studyEric Lawitz, Mark S Sulkowski, Reem Ghalib, et al.Journal of Geodesy|January 11, 2020
Modernizing and Expanding the NASA Space Geodesy Network to Meet Future Geodetic RequirementsS M Merkowitz, S Bolotin, P Elosegui, et al.Pageof 177